Cargando…
New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
Philadelphia-negative myeloproliferative neoplasms (MPN) are aggressive diseases characterized by clonal proliferation of myeloid stem cells. The clonal process leads to excessive red cells production, platelets production, and bone marrow fibrosis. According to the phenotype, MPN can be classified...
Autor principal: | Penna, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619471/ https://www.ncbi.nlm.nih.gov/pubmed/34833399 http://dx.doi.org/10.3390/medicina57111181 |
Ejemplares similares
-
JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms
por: Bellido, Mar, et al.
Publicado: (2012) -
Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons
por: Leiva, Orly, et al.
Publicado: (2023) -
Novel therapeutics in myeloproliferative neoplasms
por: Venugopal, Sangeetha, et al.
Publicado: (2020) -
Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
por: Gerke, Margo B., et al.
Publicado: (2023) -
Angiogenesis in myeloproliferative neoplasms, new markers and future directions
por: Medinger, Michael, et al.
Publicado: (2014)